The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: The current evidence

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 6, 2009, Pages 467-472

  Leeman, L ^a   Acharya, U ^b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Anovulation; Insulin resistance; Metformin; PCOS

Indexed keywords

METFORMIN;

ANOVULATION; FEMALE; FEMALE INFERTILITY; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; OVARY FUNCTION; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; OVULATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

ANOVULATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; METFORMIN; PATIENT SELECTION; POLYCYSTIC OVARY SYNDROME;

EID: 69349103226     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610902829414     Document Type: Review

References (42)

1. Al-Inany H, Johnson N. 2006. Drugs for anovulatory infertility in polycystic ovary syndrome. British Medical Journal 332:1461-1462. (Pubitemid 44365274)
2. Balen A, Michelmore K. 2002. What is polycystic ovary syndrome? Human Reproduction 17:2219-2227.
3. Braude P, Taylor A, editors. 2004. ABC of subfertility. London: British Medical Journal Publishing.
4. Casper RF, Mitwally MF. 2006. Review: aromatase inhibitors for ovulation induction. Journal of Clinical Endocrinology and Metabolism 91:760-771.
5. Dale MM, Haylett DG. 2004. Pharmacology condensed. London: Churchill Livingstone.
6. De Leo V, La Marca A, Petraglia F. 2003. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocrine Reviews 24:633-667. (Pubitemid 37330585)
7. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174. (Pubitemid 19250404)
8. Ehrmann DA. 2005. Polycystic ovary syndrome. New England Journal of Medicine 352:1223-1236.
9. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. 1997. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 82:524-530. (Pubitemid 27068623)
10. Fleming R, Hopkinson ZE, Wallace M, Greer IA, Sattar N. 2002. Ovarian function and metabolic factors in women with oligomenorrhoea treated with metformin in a randomised double blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 87:569-574. (Pubitemid 34158220)
11. Guzick DS. 2007. Treating the polycystic ovary syndrome the old-fashioned way. New England Journal of Medicine 356:622-624. (Pubitemid 46220823)
12. Homburg R. 2003. The management of infertility associated with polycystic ovary syndrome. Reproductive Biology and Endocrinology 1:109. (Pubitemid 39130416)
13. Hopkinson ZEC, Sattar N, Fleming R, Greer IA. 1998. Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. British Medical Journal 317:329-332. (Pubitemid 28353831)
14. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. 2002. Effects of metformin on early pregnancy loss in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87:524-529. (Pubitemid 34158214)
15. Kashyap S, Wells GA, Rosenwaks Z. 2004. Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Human Reproduction 19:2474-2483. (Pubitemid 39481270)
16. Kumari AS, Haq A, Jayasundaram R, Abdel-Wareth LO, al Hai Alvares SA. 2005. Metformin monotherapy in lean women with polycystic ovary syndrome. Reproductive BioMedicine Online 10:100-104.
17. Ledger WL, Clark T. 2003. Long-term consequences of polycystic ovary syndrome. RCOG Guidelines No. 33. Available at: http://www.rcog.org.uk/ resources/Public/pdf/Polys-Ovary-Syndrome-No33.pdf (Accessed 15 March 2007).
18. Legro RS, Myers E. 2004. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction 19:1697-1704.
19. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA et al. 2007. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine 356:551-566. (Pubitemid 46220816)
20. Lord JM, Flight IHK, Norman RJ. 2003a. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 327:951.
21. Lord JM, Flight IHK, Norman RJ. 2003b. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews 3:CD003053.
22. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, et al. 2000. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomised, double-blind, placebo-controlled 6 month trial, followed by open, long-term clinical evaluation. Journal of Clinical Endocrinology and Metabolism 85:139-146. (Pubitemid 32268804)
23. Moll E, Bossuyt PMM, Korevaar JC, Lambalk CB, van der Veen F. 2006. Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. British Medical Journal 332:1485-1509. (Pubitemid 44365283)
24. Nawrocka J, Starczewski A. 2007. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Gynecological Endocrinology 23:231-237. (Pubitemid 46763722)
25. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. 1998. Effects of metformin and clomiphene-induced ovulation in the polycystic ovary syndrome. New England Journal of Medicine 338:1876-1880. (Pubitemid 28287859)
26. Neveu N, Granger L, St-Michel P, Lavoie HB. 2007. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement in 154 women with polycystic ovary syndrome. Fertility and Sterility 87:113-120. (Pubitemid 46013871)
27. Norman RJ. 2004. Metformin - comparison with other therapies in ovulation induction in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89:4797-4800. (Pubitemid 39391409)
28. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. 2001. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Human Reproduction 16:1995-1998. (Pubitemid 32916235)
29. Norman RJ, Davies MJ, Lord J, Moran LJ. 2002. The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 13:251-257. (Pubitemid 36733970)
30. Norman R, Wu R, Stankiewicz MT. 2004. Polycystic ovary syndrome. MJA Practice Essentials-Endocrinology 180:132-137.
31. Palomba S, Orio F, Nardo LG, Falbo A, Russo T, Corea D, et al. 2004. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 89:4801-4809. (Pubitemid 39391410)
32. Palomba S, Orio F, Falbo A, Manguso F, Russo T, Cascella T, et al. 2005. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 90:4068-4074. (Pubitemid 41058174)
33. Palomba S, Falbo A, Orio F, Tolino A, Zullo F. 2008a. Efficacy predictors for metformin and clomiphene citrate in anovulatory infertile patients with polycystic ovary syndrome. Fertility and Sterility. Published online April 26, 2008.
34. Palomba S, Oppedisana R, Tolino A, Orio F, Zullo F. 2008b. Metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview. Reproductive BioMedicine Online 16:327-335.
35. Pasquali R, Gambineri A. 2006. Insulin-sensitizing agents in polycystic ovary syndrome. European Journal of Endocrinology 154:763-775. (Pubitemid 43997712)
36. Richardson MR. 2003. Current perspectives in polycystic ovary syndrome. American Family Physician 68.
37. Rodriguez G, Faundes-Latham A, Atkinson LE. 1976. An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives. Studies in Family Planning 7:42-51.
38. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Working Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41-47.
39. Siebert TI, Kruger TF, Steyn DW, Nosarka S. 2006. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertility and Sterility 86:1432-1437. (Pubitemid 44602073)
40. Sinawat S, Buppasiri P, Lumbiganon P, Pattanittum P. 2007. Long versus short-course treatment with metformin plus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 1:CD006226.
41. Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P. 2006. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors. Clinical Endocrinology 65:655-659. (Pubitemid 44583828)
42. Thessaloniki ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. 2008. Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction 23:462-477.